Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland News Journal.

Amaroq Minerals Announces Key Agreements in Preparation for Gold Production in Nalunaq
Reykjavík, Nov. 15, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Amaroq Minerals Announces Key Agreements in Preparation for Gold Production in Nalunaq TORONTO, ONTARIO – November 15, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland:...

Greenland wants Chinese investment amid ‘new world order’
(MENAFN) Greenland is exploring the possibility of attracting Chinese investment to boost its mining industry, citing strained ties with the U.S. and limited involvement from the EU, according to Business and Mineral Resources Minister Naaja...

Tania Zarak Announces Season Finale of 'Cable a Tierra' and Upcoming Season Two
Acclaimed podcast to conclude its first season on December 16; new episodes return in February 2025. REYKJAVÍK, ICELAND, December 9, 2024 /EINPresswire.com/ -- International producer and cultural expert Tania Zarak is set to air the season...

Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
REYKJAVIK, Iceland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Citi’s...

Notice of Results and Investor Presentation
Reykjavík, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (“Amaroq Minerals” or the “Company”) Notice of Results and Investor Presentation TORONTO, ONTARIO – 7 November 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine...

Holding(s) in Company
Reykjavík, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK...

Plan3 Launches the Airline ImPax Report, New Monthly Research Helping Airlines Improve Passenger Disruption Management
Leveraging Disruption Data to Transform Airline Recovery Strategies and Enhance Customer Experience REYKJAVIK, ICELAND, December 5, 2024 /EINPresswire.com/ -- Each year, hundreds of millions of passengers are impacted by delays and...

Holding(s) in Company
Reykjavík, Oct. 31, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
REYKJAVIK, Iceland, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first nine...

Miscellaneous
Reykjavik, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Appointment of Nomad and Joint Broker TORONTO, ONTARIO – October 28, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land...

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...

Successful Completion of 2024 Exploration Field Season
Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Successful Completion of 2024 Exploration Field Season **Completion of full 2024 >8,600m exploration programme ahead of schedule** ***First drilling...

Schedule 2(g) Disclosure
Reykjavik, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Schedule 2(g) Disclosure TORONTO, ONTARIO – 22 October 2024 - Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development...

Block Listing Six Monthly Return
Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Block Listing Six Monthly Return TORONTO, ONTARIO – October 24, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ First North: AMRQ), an independent mine development company...

Total Voting Rights and Exercise of Stock Options
Reykjavik, Oct. 14, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Total Voting Rights and Exercise of Stock Options TORONTO, ONTARIO – 14 October 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an...

Holding(s) in Company
Reykjavik, Oct. 14, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024
Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI) Inclusion criteria include minimum market capitalization and daily trading volumes REYKJAVIK, Iceland, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a...

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines...

Person Discharging Managerial Functions
Reykjavik, Oct. 07, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Director/PDMR Shareholding - Notification of Transactions of Directors/Persons Discharging Managerial Responsibilities (PDMRs) TORONTO, ONTARIO – October 7, 2024 – Amaroq...